Login to Your Account

NewCo News

Galera's Small-Molecule Shields to Protect Against Superoxide

By Jennifer Boggs
Managing Editor

Wednesday, January 2, 2013
Galera Therapeutics Inc., a 2009 start-up based on the approach of treating disease by targeting superoxide, came out of stealth mode in December with a new CEO and a Series A financing of $11 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription